{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:12:08Z","timestamp":1792588328038,"version":"4.5.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Hemochromatosis is a genetic disorder characterized by excessive absorption and accumulation of iron in the body. It is one of the most common inherited disorders. The excess iron deposition can cause damage to various organs, including the liver, heart, pancreas, and joints. If left untreated, hemochromatosis can lead to serious complications such as cirrhosis, diabetes, heart failure, and increased risk of certain cancers. Iron overload in hemochromatosis significantly affects the cardiovascular system, leading to morbidity and mortality. This article reviews the current literature describing the pathogenesis and various cardiovascular manifestations of hemochromatosis, including dilated cardiomyopathy, conduction abnormalities, heart failure, cardiac fibrosis, myocardial infarction, and valvular heart disease. This article aims to provide a detailed understanding of the cardiovascular manifestations associated with hemochromatosis and their underlying mechanisms through a review of current literature in publicly available databases.<\/jats:p>","DOI":"10.1097\/crd.0000000000000622","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T14:00:11Z","timestamp":1698328811000},"page":"359-364","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Cardiovascular Manifestations of Hemochromatosis: A Review of Pathophysiology, Mechanisms, and Treatment Options"],"prefix":"10.1097","volume":"33","author":[{"given":"Shamim","family":"Ahmed","sequence":"first","affiliation":[{"name":"Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY"},{"name":"Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish A.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY"},{"name":"Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"key":"R2-20250606","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/advances\/nmab035","article-title":"Ethnic differences in iron status.","volume":"12","author":"Kang","year":"2021","journal-title":"Adv Nutr"},{"key":"R3-20250606","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1373\/clinchem.2006.068684","article-title":"Hereditary hemochromatosis: genetic complexity and new diagnostic approaches.","volume":"52","author":"Swinkels","year":"2006","journal-title":"Clin Chem"},{"key":"R4-20250606","doi-asserted-by":"crossref","first-page":"731","DOI":"10.21037\/atm-20-5512","article-title":"Revisiting hemochromatosis: genetic vsphenotypic manifestations.","volume":"9","author":"Anderson","year":"2021","journal-title":"Ann Transl Med"},{"key":"R5-20250606","first-page":"e20009","article-title":"Hereditary hemochromatosis: a cardiac perspective.","volume":"13","author":"Joshi","year":"2021","journal-title":"Cureus"},{"key":"R6-20250606","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/15353702221076397","article-title":"Iron overload cardiomyopathy: using the latest evidence to inform future applications.","volume":"247","author":"Kumfu","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"R7-20250606","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3324\/haematol.2016.160432","article-title":"Pathophysiological consequences and benefits of HFE mutations: 20 years of research.","volume":"102","author":"Hollerer","year":"2017","journal-title":"Haematologica"},{"key":"R8-20250606","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3390\/cells11172726","article-title":"Molecular mechanisms of ferroptosis and relevance to cardiovascular disease.","volume":"11","author":"Xie","year":"2022","journal-title":"Cells"},{"key":"R9-20250606","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000208988","article-title":"Hemojuvelin: the hepcidin story continues.","volume":"32","author":"Malyszko","year":"2009","journal-title":"Kidney Blood Press Res"},{"key":"R10-20250606","doi-asserted-by":"crossref","first-page":"230182","DOI":"10.1155\/2015\/230182","article-title":"Iron-induced damage in cardiomyopathy: oxidative-dependent and independent mechanisms.","volume":"2015","author":"Gammella","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"R11-20250606","doi-asserted-by":"crossref","first-page":"740573","DOI":"10.1155\/2013\/740573","article-title":"Prooxidant mechanisms in iron overload cardiomyopathy.","volume":"2013","author":"Cheng","year":"2013","journal-title":"Biomed Res Int"},{"key":"R12-20250606","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.bbadis.2018.08.030","article-title":"Role of iron metabolism in heart failure: from iron deficiency to iron overload.","volume":"1865","author":"Zhang","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"R13-20250606","first-page":"847","article-title":"The evaluation of iron deficiency and iron overload.","volume":"118","author":"Gattermann","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"R14-20250606","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3390\/ijms13021497","article-title":"Molecular diagnostic and pathogenesis of hereditary hemochromatosis.","volume":"13","author":"Santos","year":"2012","journal-title":"Int J Mol Sci"},{"key":"R15-20250606","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/diagnostics11020256","article-title":"The importance of multimodality imaging in the diagnosis and management of patients with infiltrative cardiomyopathies: an update.","volume":"11","author":"Sasc\u0103u","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"R16-20250606","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1182\/asheducation-2009.1.195","article-title":"Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) study.","author":"McLaren","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R17-20250606","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJMoa041534","article-title":"Hemochromatosis and iron-overload screening in a racially diverse population.","volume":"352","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"key":"R18-20250606","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10238-022-00799-z","article-title":"Liver biopsy for assessment of chronic liver diseases: a synopsis.","volume":"23","author":"Chowdhury","year":"2023","journal-title":"Clin Exp Med"},{"key":"R19-20250606","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hfc.2017.12.003","article-title":"Genetic infiltrative cardiomyopathies.","volume":"14","author":"Sweet","year":"2018","journal-title":"Heart Fail Clin"},{"key":"R20-20250606","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00109-005-0029-x","article-title":"Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy.","volume":"84","author":"Oudit","year":"2006","journal-title":"J Mol Med (Berl)"},{"key":"R21-20250606","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","article-title":"Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment.","volume":"16","author":"Murphy","year":"2010","journal-title":"J Card Fail"},{"key":"R22-20250606","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1056\/NEJM199701233360407","article-title":"Restrictive cardiomyopathy.","volume":"336","author":"Kushwaha","year":"1997","journal-title":"N Engl J Med"},{"key":"R23-20250606","doi-asserted-by":"crossref","first-page":"181","DOI":"10.31083\/j.rcm.2020.02.65","article-title":"Clinical evaluation of infiltrative cardiomyopathies resulting in heart failure with preserved ejection fraction.","volume":"21","author":"Madan","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"R24-20250606","first-page":"448","article-title":"Evaluation of myocardial iron overload by T2* cardiovascular magnetic resonance imaging.","volume":"32","author":"Cheong","year":"2005","journal-title":"Tex Heart Inst J"},{"key":"R25-20250606","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3389\/fphys.2018.01615","article-title":"Cellular electrophysiology of iron-overloaded cardiomyocytes.","volume":"9","author":"Siri-Angkul","year":"2018","journal-title":"Front Physiol"},{"key":"R26-20250606","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI7664","article-title":"Iron overload diminishes atherosclerosis in apoE-deficient mice.","volume":"107","author":"Kirk","year":"2001","journal-title":"J Clin Invest"},{"key":"R27-20250606","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/jama.1994.03520030073031","article-title":"Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease.","volume":"272","author":"Miller","year":"1994","journal-title":"JAMA"},{"key":"R28-20250606","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.33549\/physiolres.933589","article-title":"The role of iron in the pathogenesis of atherosclerosis.","volume":"66","author":"Kraml","year":"2017","journal-title":"Physiol Res"},{"key":"R29-20250606","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11897-017-0346-8","article-title":"Therapeutic strategies targeting inherited cardiomyopathies.","volume":"14","author":"Varian","year":"2017","journal-title":"Curr Heart Fail Rep"},{"key":"R30-20250606","first-page":"499","article-title":"The treatment of secondary hemochromatosis.","volume":"106","author":"Gattermann","year":"2009","journal-title":"Dtsch Arztebl Int"},{"key":"R31-20250606","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","article-title":"Iron overload cardiomyopathy in clinical practice.","volume":"124","author":"Kremastinos","year":"2011","journal-title":"Circulation"},{"key":"R32-20250606","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.14309\/ajg.0000000000000315","article-title":"ACG Clinical guideline: hereditary hemochromatosis.","volume":"114","author":"Kowdley","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R33-20250606","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1007\/s11606-018-4669-2","article-title":"Diagnosis and management of genetic iron overload disorders.","volume":"33","author":"Palmer","year":"2018","journal-title":"J Gen Intern Med"},{"key":"R34-20250606","first-page":"CD011647","article-title":"Interventions for hereditary haemochromatosis: an attempted network meta-analysis.","volume":"3","author":"Buzzetti","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R35-20250606","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijcard.2021.07.060","article-title":"Cardiovascular manifestations in hospitalized patients with hemochromatosis in the United States.","volume":"342","author":"Udani","year":"2021","journal-title":"Int J Cardiol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T14:00:26Z","timestamp":1749218426000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000622","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]}}}